Related Experiment Video
Updated: May 21, 2026
08:21
Intradermal Microdialysis: An Approach to Investigating Novel Mechanisms of Microvascular Dysfunction in Humans
Published on: July 21, 2023
[Aspirin use in cardiovascular disease prevention: a population-based study]
Carolina Avila Vianna1, David Alejandro González, Alicia Matijasevich
1Programa de Pós-graduação em Epidemiologia, Universidade Federal de Pelotas, Pelotas, Brasil. caruvianna@hotmail.com
Cadernos De Saude Publica
|June 6, 2012
Summary
Aspirin use for cardiovascular disease prevention was low in Brazil, with only 24.8% for primary and 34.3% for secondary prevention. This indicates a gap in recommended cardiovascular care.
Area of Science:
- Cardiology
- Public Health
- Epidemiology
Context:
- Cardiovascular diseases (CVD) are a leading cause of mortality globally.
- Aspirin is a widely recommended medication for both primary and secondary prevention of CVD.
- Understanding aspirin usage patterns is crucial for public health initiatives.
Purpose:
- To estimate the prevalence of aspirin use for primary and secondary cardiovascular disease prevention.
- To analyze aspirin use based on demographic, socioeconomic, and lifestyle factors in Pelotas, Brazil.
Summary:
- A population-based cross-sectional study in Brazil (2010) assessed aspirin use.
- Prevalence was 24.8% for primary prevention (age >40 with risk factors) and 34.3% for secondary prevention (history of stroke/angina/myocardial infarction).
- Aspirin use varied by demographics, socioeconomic status, and lifestyle, but overall prevalence was below recommended levels.
Impact:
- Findings highlight suboptimal aspirin utilization for cardiovascular disease prevention in the studied population.
- Results can inform targeted interventions to improve adherence to clinical guidelines.
- This research contributes to the evidence base for public health strategies aimed at reducing CVD burden.
Related Concept Videos
01:26Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
01:23Assessment of the Cardiovascular System I: Subjective Data
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...